vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Medpace Holdings, Inc. (MEDP). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $708.5M, roughly 1.2× Medpace Holdings, Inc.). Medpace Holdings, Inc. runs the higher net margin — 19.1% vs 0.5%, a 18.5% gap on every dollar of revenue. On growth, Medpace Holdings, Inc. posted the faster year-over-year revenue change (32.0% vs 7.5%). Over the past eight quarters, Medpace Holdings, Inc.'s revenue compounded faster (17.7% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Medpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
ACHC vs MEDP — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $708.5M |
| Net Profit | $4.5M | $135.1M |
| Gross Margin | — | — |
| Operating Margin | — | 21.6% |
| Net Margin | 0.5% | 19.1% |
| Revenue YoY | 7.5% | 32.0% |
| Net Profit YoY | -50.8% | 15.5% |
| EPS (diluted) | $0.05 | $4.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $708.5M | ||
| Q3 25 | $851.6M | $659.9M | ||
| Q2 25 | $869.2M | $603.3M | ||
| Q1 25 | $770.5M | $558.6M | ||
| Q4 24 | $774.2M | $536.6M | ||
| Q3 24 | $815.6M | $533.3M | ||
| Q2 24 | $796.0M | $528.1M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $135.1M | ||
| Q3 25 | $36.2M | $111.1M | ||
| Q2 25 | $30.1M | $90.3M | ||
| Q1 25 | $8.4M | $114.6M | ||
| Q4 24 | $32.6M | $117.0M | ||
| Q3 24 | $68.1M | $96.4M | ||
| Q2 24 | $78.5M | $88.4M |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 21.6% | ||
| Q3 25 | 4.7% | 21.5% | ||
| Q2 25 | 5.8% | 20.9% | ||
| Q1 25 | 1.7% | 20.3% | ||
| Q4 24 | 4.9% | 23.4% | ||
| Q3 24 | 12.1% | 21.1% | ||
| Q2 24 | 13.4% | 19.9% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 19.1% | ||
| Q3 25 | 4.3% | 16.8% | ||
| Q2 25 | 3.5% | 15.0% | ||
| Q1 25 | 1.1% | 20.5% | ||
| Q4 24 | 4.2% | 21.8% | ||
| Q3 24 | 8.4% | 18.1% | ||
| Q2 24 | 9.9% | 16.7% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $4.65 | ||
| Q3 25 | $0.40 | $3.86 | ||
| Q2 25 | $0.33 | $3.10 | ||
| Q1 25 | $0.09 | $3.67 | ||
| Q4 24 | $0.36 | $3.67 | ||
| Q3 24 | $0.74 | $3.01 | ||
| Q2 24 | $0.85 | $2.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $497.0M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $459.1M |
| Total Assets | $5.5B | $2.0B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $497.0M | ||
| Q3 25 | $118.7M | $285.4M | ||
| Q2 25 | $131.4M | $46.3M | ||
| Q1 25 | $91.2M | $441.4M | ||
| Q4 24 | $76.3M | $669.4M | ||
| Q3 24 | $82.1M | $656.9M | ||
| Q2 24 | $77.2M | $510.9M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $459.1M | ||
| Q3 25 | $3.1B | $293.6M | ||
| Q2 25 | $3.1B | $172.4M | ||
| Q1 25 | $3.0B | $593.6M | ||
| Q4 24 | $3.1B | $825.5M | ||
| Q3 24 | $3.0B | $881.4M | ||
| Q2 24 | $3.0B | $763.6M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $2.0B | ||
| Q3 25 | $6.4B | $1.8B | ||
| Q2 25 | $6.3B | $1.6B | ||
| Q1 25 | $6.1B | $1.9B | ||
| Q4 24 | $6.0B | $2.1B | ||
| Q3 24 | $5.9B | $2.1B | ||
| Q2 24 | $5.7B | $1.9B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $192.7M |
| Free Cash FlowOCF − Capex | — | $188.1M |
| FCF MarginFCF / Revenue | — | 26.6% |
| Capex IntensityCapex / Revenue | — | 0.6% |
| Cash ConversionOCF / Net Profit | 13.78× | 1.43× |
| TTM Free Cash FlowTrailing 4 quarters | — | $681.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $192.7M | ||
| Q3 25 | $73.2M | $246.2M | ||
| Q2 25 | $133.5M | $148.5M | ||
| Q1 25 | $11.5M | $125.8M | ||
| Q4 24 | $116.7M | $190.7M | ||
| Q3 24 | $163.1M | $149.1M | ||
| Q2 24 | $171.1M | $116.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $188.1M | ||
| Q3 25 | $-63.0M | $235.5M | ||
| Q2 25 | $-34.2M | $142.4M | ||
| Q1 25 | $-163.2M | $115.8M | ||
| Q4 24 | $-86.8M | $183.0M | ||
| Q3 24 | $-27.1M | $138.5M | ||
| Q2 24 | $16.9M | $103.5M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 26.6% | ||
| Q3 25 | -7.4% | 35.7% | ||
| Q2 25 | -3.9% | 23.6% | ||
| Q1 25 | -21.2% | 20.7% | ||
| Q4 24 | -11.2% | 34.1% | ||
| Q3 24 | -3.3% | 26.0% | ||
| Q2 24 | 2.1% | 19.6% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.6% | ||
| Q3 25 | 16.0% | 1.6% | ||
| Q2 25 | 19.3% | 1.0% | ||
| Q1 25 | 22.7% | 1.8% | ||
| Q4 24 | 26.3% | 1.4% | ||
| Q3 24 | 23.3% | 2.0% | ||
| Q2 24 | 19.4% | 2.4% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.43× | ||
| Q3 25 | 2.02× | 2.22× | ||
| Q2 25 | 4.43× | 1.65× | ||
| Q1 25 | 1.37× | 1.10× | ||
| Q4 24 | 3.58× | 1.63× | ||
| Q3 24 | 2.39× | 1.55× | ||
| Q2 24 | 2.18× | 1.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
MEDP
| Metabolic | $249.8M | 35% |
| Oncology | $195.9M | 28% |
| Other | $88.3M | 12% |
| Central Nervous System | $73.2M | 10% |
| Cardiology | $63.0M | 9% |
| Antiviral And Anti Infective | $38.3M | 5% |
| Related Party | $10.3M | 1% |
